Chemical Communications,
Год журнала:
2024,
Номер
unknown
Опубликована: Дек. 27, 2024
A
covalent
organic
framework-based
multifunctional
nanomedicine,
CuO2@COF-SNO,
which
can
produce
reactive
oxygen
and
nitrogen
species
(ROS/RNS)
to
enhance
chemodynamic
therapy
of
tumors.
Theranostics,
Год журнала:
2024,
Номер
15(3), С. 993 - 1016
Опубликована: Дек. 2, 2024
Immunotherapy
has
transformed
current
cancer
management,
and
it
achieved
significant
progress
over
last
decades.
However,
an
immunosuppressive
tumor
microenvironment
(TME)
diminishes
the
effectiveness
of
immunotherapy
by
suppressing
activity
immune
cells
facilitating
immune-evasion.
Adenosine
monophosphate-activated
protein
kinase
(AMPK),
a
key
modulator
cellular
energy
metabolism
homeostasis,
gained
growing
attention
in
anti-tumor
immunity.
Metformin
is
usually
considered
as
cornerstone
diabetes
its
role
activating
AMPK
pathway
also
been
extensively
explored
therapy
although
findings
on
remain
inconsistent.
nanomedicine
formulation
found
to
hold
potential
reprogramming
TME
through
immunometabolic
modulation
both
cells.
This
review
elaborates
foundation
via
metformin-based
nanomedicines,
offering
valuable
insights
for
next
generation
therapy.
Nano Letters,
Год журнала:
2024,
Номер
24(22), С. 6767 - 6777
Опубликована: Май 21, 2024
Efforts
to
prolong
the
blood
circulation
time
and
bypass
immune
clearance
play
vital
roles
in
improving
therapeutic
efficacy
of
nanoparticles
(NPs).
Herein,
a
multifunctional
nanoplatform
(BPP@RTL)
that
precisely
targets
tumor
cells
is
fabricated
by
encapsulating
ultrasmall
phototherapeutic
agent
black
phosphorus
quantum
dot
(BPQD),
chemotherapeutic
drug
paclitaxel
(PTX),
immunomodulator
PolyMetformin
(PM)
hybrid
membrane-camouflaged
liposomes.
Specifically,
cell
membrane
coating
derived
from
fusion
cancer
red
displays
excellent
targeting
efficiency
long
property
due
innate
features
both
membranes.
After
collaboration
with
aPD-L1-based
checkpoint
blockade
therapy,
boosted
immunotherapeutic
effect
obtained
elevated
dendritic
maturation
T
activation.
Significantly,
laser-irradiated
BPP@RTL
combined
aPD-L1
effectively
eliminates
primary
tumors
inhibits
lung
metastasis
4T1
breast
model,
offering
promising
treatment
plan
develop
personalized
antitumor
strategy.
Advanced Functional Materials,
Год журнала:
2024,
Номер
34(33)
Опубликована: Май 16, 2024
Abstract
Piezocatalysts,
because
of
their
mechano‐electrical
conversion
properties,
are
exploited
for
various
medical
applications,
such
as
sterilization,
tissue
engineering,
biosensing,
and
disease
theranostics.
In
particular,
based
on
the
unique
advantage
piezoelectric
effect,
piezocatalytic
therapy
(PCT)
has
been
developed
a
novel
promising
candidate
tumor
therapy.
To
optimize
utilization
piezocatalysts
in
therapy,
comprehensive
understanding
antitumor
mechanism
associated
with
these
materials
is
imperative.
Here,
action
principle
elucidated
by
investigating
piezocatalysts,
reactants,
energy
inputs,
products.
Subsequently,
mechanisms
PCT
have
extensively
discussed
recapitulative
follows:
restraining
cell
proliferation,
inducing
programmed
death,
hindering
metastasis,
inhibiting
angiogenesis,
enhancing
immunity.
Additionally,
optimized
therapeutic
outcomes
PCT‐centric
synergistic
cancer
systematically
described.
Finally,
main
challenges
future
research
directions
piezocatalysis
applied
envisioned.
It
believed
that
will
serve
new‐generation
ingenious
tool
treatment.
Dendritic
cells
(DCs)
play
a
crucial
role
in
initiating
antitumor
immune
responses.
However,
the
tumor
environment,
dendritic
often
exhibit
impaired
antigen
presentation
and
adopt
an
immunosuppressive
phenotype,
which
hinders
their
function
reduces
ability
to
efficiently
present
antigens.
Here,
dual
catalytic
oxide
nanosponge
(DON)
doubling
as
remotely
boosted
catalyst
inducer
of
programming
DCs
program
therapy
is
reported.
Intravenous
delivery
DON
enhances
accumulation
via
marginated
target.
At
site,
incorporates
cerium
nanozyme
(CeO
Small Structures,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 5, 2025
Tumors
endanger
the
lives
of
individuals
worldwide.
They
form
and
metastatize
to
nearby
distant
tissues
organs
in
several
ways,
which
greatly
increase
difficulty
therapy.
The
continuous
development
progress
nanomedicine
has
provided
new
insights
treatment
tumors.
Owing
their
excellent
properties
barium
titanate
(BaTiO
3
,
BTO),
especially
piezoelectricity,
BTO‐based
nanomaterials
have
become
popular
among
tumor
therapy
researchers
recent
years.
sonodynamic
(SDT)
is
considerably
advanced
than
traditional
therapies.
Herein,
first,
properties,
structure,
preparation
technology,
working
mechanism
BTO
under
ultrasonic
stimulation
systematically
introduced.
Second,
research
BTO‐mediated
SDT,
electrical
therapy,
SDT‐derived
multimodal
synergistic
field
reviewed.
Third,
biocompatibility,
biodistribution,
bioelimination
summarized.
Finally,
current
problems
associated
with
SDT
as
well
potential
obstacles
opportunities
oncology
other
biomedical
fields
are
summarized
prospected.
Inorganics,
Год журнала:
2025,
Номер
13(3), С. 71 - 71
Опубликована: Фев. 26, 2025
As
a
non-invasive
modality,
sonodynamic
therapy
(SDT)
offers
several
advantages
in
cancer
treatment,
including
deep
tissue
penetration
and
precise
spatiotemporal
control,
resulting
from
the
interplay
between
low-intensity
ultrasound
sonosensitizers.
Piezoelectric
materials,
known
for
their
remarkable
capacity
of
interconversion
mechanical
electrical
energy,
have
garnered
considerable
attention
biomedical
applications,
which
can
serve
as
pivotal
sonosensitizers
SDT.
These
materials
generate
internal
electric
fields
via
ultrasound-induced
deformation,
modulates
alteration
charge
carriers,
thereby
initiating
surface
redox
reactions
to
reactive
oxygen
species
(ROS)
realizing
therapeutic
efficacy
This
review
provides
an
in-depth
exploration
piezoelectric
utilized
SDT,
with
particular
emphasis
on
recent
innovations,
elucidation
underlying
mechanisms,
optimization
strategies
advanced
materials.
Furthermore,
incorporation
immunotherapy,
photodynamic,
chemodynamic,
chemotherapy
is
explored,
emphasizing
potential
enhance
outcomes.
By
examining
basic
principles
effect
its
contributions
this
sheds
light
promising
applications
oncology.
It
also
highlights
future
directions
improving
these
expanding
clinical
utility
tumor
therapy.
Journal of Materials Chemistry B,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 1, 2025
The
commonalities
and
differences
of
EPSF
catalysts
in
organic
pollutant
degradation
tumor-targeted
therapy
are
summarized,
focusing
on
catalytic
mechanisms,
material
systems,
performance
enhancement
strategies,
catalyst
design.
Journal of Materials Chemistry B,
Год журнала:
2024,
Номер
12(32), С. 7837 - 7847
Опубликована: Янв. 1, 2024
The
dense
extracellular
matrix
(ECM)
in
the
tumor
microenvironment
forms
an
abnormal
physical
barrier,
which
impedes
delivery
and
penetration
of
nanomedicines
hinders
their
therapeutic
efficacy.
Herein,
we
synthesize
matrix-degrading
soft-nanocapsules
composed
human
serum
albumin
(HSA)
hyaluronidase
(HAase)
for
overcoming
obstruction
ECM
microenvironment.
albumin/hyaluronidase
soft-nanocapsules,
referred
to
as
HSA/HAase
SNCs,
possess
a
uniform
diameter,
inward
hollow
structure,
wrinkled
morphology.